DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 59 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $276 | -74.8% | 20,032 | -69.8% | 0.00% | -100.0% |
| Q1 2024 | $1,094 | -4.3% | 66,228 | -15.4% | 0.00% | -50.0% |
| Q4 2023 | $1,143 | +43.2% | 78,299 | +20.5% | 0.00% | +100.0% |
| Q3 2023 | $798 | -8.5% | 65,005 | -11.0% | 0.00% | 0.0% |
| Q2 2023 | $872 | +20.3% | 73,066 | +34.7% | 0.00% | 0.0% |
| Q1 2023 | $725 | -35.0% | 54,235 | +4.7% | 0.00% | -50.0% |
| Q4 2022 | $1,115 | -99.9% | 51,813 | +0.0% | 0.00% | 0.0% |
| Q3 2022 | $1,037,000 | +198.0% | 51,790 | +166.0% | 0.00% | – |
| Q2 2022 | $348,000 | +80.3% | 19,468 | +0.3% | 0.00% | – |
| Q1 2022 | $193,000 | +40.9% | 19,410 | +139.6% | 0.00% | – |
| Q4 2021 | $137,000 | – | 8,102 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,965,588 | $113,066,000 | 1.82% |
| Boxer Capital, LLC | 1,189,943 | $27,095,000 | 0.96% |
| BVF INC/IL | 918,975 | $20,925,000 | 0.78% |
| Samsara BioCapital, LLC | 202,500 | $4,611,000 | 0.57% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 818,980 | $18,648,000 | 0.33% |
| Perceptive Advisors | 1,512,094 | $34,430,000 | 0.22% |
| Rock Springs Capital Management LP | 373,739 | $8,510,000 | 0.17% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 434,423 | $9,892,000 | 0.13% |
| HealthCor Management, L.P. | 103,717 | $2,362,000 | 0.09% |
| VIKING GLOBAL INVESTORS LP | 1,341,396 | $30,544,000 | 0.09% |